Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)

Clinical trial NCT01406327 · COMPLETED

Trial details

NCT number: NCT01406327
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension, Pulmonary

Start date: 2010-12-14
Primary completion: 2020-02-28
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.